2-(甲基氨基)-N-(4-甲基苯基)乙酰胺盐酸盐 | 64642-17-7

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 2-(甲基氨基)-N-(4-甲基苯基)乙酰胺盐酸盐
• 英文名称: N-methyl-glycine 4-methyl-anilide
• 英文别名: N-methyl-glycine p-toluidide；N-Methyl-glycin-p-toluidid；Sarkosin-p-toluidid；2-(methylamino)-N-(4-methylphenyl)acetamide
• CAS: 64642-17-7
• 化学式: C₁₀H₁₄N₂O
• mdl: MFCD03948088
• 分子量: 178.234
• InChiKey: ZBYCJXKBBVZZOF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  41.1
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2924299090

反应信息

• 作为反应物：
  描述：

  2-(甲基氨基)-N-(4-甲基苯基)乙酰胺盐酸盐 、 二苯基(异硫氰酸基)磷酸酯 生成 5-diphenoxyphosphoryl-3-methyl-4-thio-hydantoic acid p-toluidide
  参考文献：
  名称：

  452.酰基异硫氰酸酯。第三部分 一些异硫氰酸氰酯的性质

  摘要：

  DOI：

  10.1039/jr9590002286
• 作为产物：
  描述：

  乙烷,三氯氟- 在 potassium carbonate 、 三乙胺 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 反应 28.0h， 生成 2-(甲基氨基)-N-(4-甲基苯基)乙酰胺盐酸盐
  参考文献：
  名称：

  Structure-Based Design, Synthesis, and Antifungal Activity of New Triazole Derivatives

  摘要：

  A series of new antifungal triazole derivatives with phenylacetamide side chain were rational designed and synthesized on the basis of the structural information of lanosterol 14‐demethylase (CYP51). In vitro antifungal activity assay indicated that several compounds showed higher activity than fluconazole. Especially, compound 8h showed excellent inhibitory activity against Candida albicans and Cryptococcus neoformans (MIC = 0.0156 μg/mL), suggesting that it is a promising lead for the development of novel antifungal agents. The binding mode of compound 8h was investigated by flexible molecular docking. It interacted with CACYP51 through hydrophobic and van der Waals interactions.

  DOI：

  10.1111/j.1747-0285.2011.01138.x

文献信息

• INHIBITORS OF HIV REPLICATION
  申请人：STURINO Claudio

  公开号：US20100261714A1

  公开（公告）日：2010-10-14

  Compounds of formula (I): wherein R 1 , R 2 , A 1 , A 2 , A 3 , A 4 , X and Y are as defined herein, are useful as inhibitors of HIV replication.

  式(I)的化合物： 其中R1、R2、A1、A2、A3、A4、X和Y如本文所定义，可用作HIV复制抑制剂。
• 1,4 disubstituted 3 cyano pyridone derivatives and their use as positive allosteric modulators of mGluR2 receptors
  申请人：Ortho-McNeil-Janssen Pharmaceuticals, Inc.

  公开号：EP2426125A1

  公开（公告）日：2012-03-07

  The present invention relates to novel compounds, in particular novel pyridinone derivatives according to Formula (I) wherein all radicals are defined in the application and claims. The compounds according to the invention are positive allosteric modulators of metabotropic receptors - subtype 2 ("mGluR2") which are useful for the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which the mGluR2 subtype of metabotropic receptors is involved. In particular, such diseases are central nervous system disorders selected from the group of anxiety, schizophrenia, migraine, depression, and epilepsy. The invention is also directed to pharmaceutical compositions and processes to prepare such compounds and compositions, as well as to the use of such compounds for the prevention and treatment of such diseases in which mGluR2 is involved.

  本发明涉及新型化合物，特别是符合式 (I) 的新型吡啶酮衍生物 其中所有基团在申请和权利要求中均有定义。根据本发明的化合物是代谢受体-亚型 2（"mGluR2"）的正异位调节剂，可用于治疗或预防与谷氨酸功能障碍相关的神经和精神疾病以及涉及代谢受体的 mGluR2 亚型的疾病。特别是，这类疾病是选自焦虑症、精神分裂症、偏头痛、抑郁症和癫痫组的中枢神经系统疾病。本发明还涉及药物组合物和制备此类化合物及组合物的工艺，以及使用此类化合物预防和治疗涉及 mGluR2 的此类疾病。
• 639. Degradative studies of peptides and proteins. Part V. The formation of 2-acylimino-3-methylthiazolid-5-ones from N-acylthio-carbamoylsarcosine derivatives and their behaviour towards nucleophilic reagents
  作者：D. T. Elmore

  DOI：10.1039/jr9590003152

  日期：——
• Synthesis of Di- and Tri-substituted 2,4-Dioxo-1,3,2-diazaphospholidines and 4-Oxo-2-thioxo-1,3,2-diazaphospholidines
  作者：M. MULLIEZ、M. WAKSELMAN

  DOI：10.1055/s-1977-24451

  日期：——
• 1, 4-DISUBSTITUTED 3-CYANO-PYRIDONE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2-RECEPTORS
  申请人：Imogai Hassan Julien

  公开号：US20100166655A1

  公开（公告）日：2010-07-01

  The present invention relates to novel compounds, in particular novel pyridinone derivatives according to Formula (I) wherein all radicals are defined in the application and claims. The compounds according to the invention are positive allosteric modulators of metabotropic receptors-subtype 2 (“mGluR2”) which are useful for the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which the mGluR2 subtype of metabotropic receptors is involved. In particular, such diseases are central nervous system disorders selected from the group of anxiety, schizophrenia, migraine, depression, and epilepsy. The invention is also directed to pharmaceutical compositions and processes to prepare such compounds and compositions, as well as to the use of such compounds for the prevention and treatment of such diseases in which mGluR2 is involved.